Hospital-at-Home (HaH) programmes are expanding rapidly across European health systems as substitutive acute care models [1,2]. As they consolidate, unplanned transfer back to hospital — termed clinical escalation — has become one of the most widely reported safety metrics in the field [3]. This is appropriate, but the current practice of reporting it as a single, undifferentiated rate may be insufficient and lead to erroneous conclusions.
